Phase I trial of cyclosporine-induced autologous graft-versus-host disease in patients with multiple myeloma undergoing high-dose chemotherapy with autologous stem-cell rescue.
Article 1997 en
Authors
SG
Sergio Giralt
DW
D. Weber
MC
M I Colome
Abstract
1 min read
Induction of autologous GVHD by posttransplant cyclosporine is feasible and well tolerated in patients with multiple myeloma.
Meletios A Dimopoulos, Raymond Alexanian, Donna Przepiorka, J. P. Hester, Börje S. Andersson, Sergio Giralt, Rakesh Mehra, Koen van Besien, KB Delasalle, Christopher L. Reading
Meletios A Dimopoulos, Raymond Alexanian, Donna Przepiorka, J. P. Hester, Börje S. Andersson, Sergio Giralt, Rakesh Mehra, Koen van Besien, KB Delasalle, Christopher L. Reading
Meletios A Dimopoulos, Ivan Špıčka, Hang Quach, Albert Oriol, Roman Hájek, Mamta Garg, Meral Beksaç, Sara Bringhen, Eirini Katodritou, Wee Joo Chng, Xavier Leleu, Shinsuke Iida, María‐Victoria Mateos, Gareth J. Morgan, Alexander Vorog, Richard Labotka, Bingxia Wang, Antonio Palumbo, Sagar Lonial
Discussion(0)
No comments yet. Be the first to comment.